Mary Catherine Tartara
**** ******** ******* ********, **** 44145 H-440-***-**** C-216-***-**** *********@*******.***
Professional Experience
Bristol Myers Squibb * Toledo/ Cleveland
Senior Therapeutic Area Specialist 4/2024 to 1/2025
● Promote Zeposia as a treatment for ulcerative colitis to gastroenterologists in northwest Ohio Division dissolved
● Utilize effective communication and presentation skills to articulate scientific and clinical data in an easy-to-understand manner to help HCPs best serve their patients
● Communicate new guidelines and product updates to physicians
● Successfully collaborate with cross-functional teams to achieve common goals
Sanofi/ Genzyme ● Ohio/ Michigan 3/2023 to 4/2024
Key Account Specialist
● Launched Kevzara (biologic IL-6) as first and only steroid sparing treatment for PMR (polymyalgia rheumatica) to rheumatologists
● Continue to support Kevzara,as treatment for Rheumatoid Arthritis by delivering clinically focused messages to introduce, launch, grow brand-share and revenue, and to consistently deliver on product goals
● Ranked 5/17 for 2024
Syneos Health/ VBI Vaccines ● Cleveland, Ohio 6/2021 to 3/2023
Vaccine Sales Specialist
● Launch a new, first and only 3 antigen, FDA approved Hepatitis B vaccine
● Promote the new updated ACIP/CDC guidelines for universal Hep B vaccination by 2025
Syneos Health/ GSK ● Cleveland, Ohio
Specialty Sales Representative
● Provide Scientific Knowledge, Business Acumen, and Customer Engagement expertise to specialist customers in support of Nucala, a GSK biologic (IL-5) product for severe eosinophilic asthma in the respiratory market for the greater Cleveland and Pittsburgh areas
Sanofi Genzyme ● Cleveland, Ohio 6/2020 to 3/2021
Senior Area Business Manager Division dissolved
● Developed and executed strategies within key accounts within the Rheumatology therapeutic area to generate product utilization for Kevzara, an injectable biologic, IL-6 inhibitor
● Cultivate solid working relationships with Rheumatologists, healthcare professionals, and patient advocacy support groups
● Collaborated with regional colleagues to proactively address customer needs, market dynamics, and trends and develop strategies to support IL-6 awareness
● Winner of multiple sales contests for market share growth, new patient starts and managed care pull through in 2020
● 123% to goal for Q1 2021
● Ranked 6/88 Q1 2021
Antares Pharma ● Cleveland, Ohio 1/2016 to 6/2020
Rheumatology Specialty Account Manager
● Market Otrexup, injectable methotrexate indicated for the management of patients with severe active Rheumatoid Arthritis (RA) and
Poly Articulate Juvenile Idiopathic (pJIA) to Rheumatologists and Dermatology in the Cleveland, Akron, Youngstown markets
● Launched XYOSTED in 2019 into Urology, Endocrinology, and high value PCP offices, bringing the first ever, sub-cue auto injector
for testosterone replacement therapy
● Develop and implement a business strategy involving the collaboration with specialty pharmacies and effective pull through in
the physician's office
● 100% to goal for 2019
Omeros • Cleveland, Ohio
Specialty Sales Representative 1/2014 to 12/2015
● Launched Omidria (only FDA approved injectable combination of phenylephrine/ ketorolac) to cataract surgeons
● Marketed Omidria through a buy and bill channel (with Medicare Part B pass-through designation)
● Ranked 10/42 for 2015
● Trained physicians and staff to implement “buy & bill” and “specialty pharmacy” reimbursement into their medical practice
● Earn, close and pull-through Omidria business with appropriate cataract surgeons at surgery centers in Cleveland, Youngstown and Pittsburgh
● Trained OR staff and assisted ophthalmologists in operating room during live procedures
● Prospect, profile and qualify accounts to be targeted; then deploy an Account-based selling approach to surgery centers and hospitals
Education
Bowling Green State University, Bowling Green, Ohio Bachelor of Arts · Concentration: Biology